Valeant buys rights for two skin medications

The Canadian Press - Valeant Pharmaceuticals International Inc. said Thursday it will pay $76 million plus additional royalties to acquire the marketing rights to skin medications Elidel and Xerese for the U.S., Canada and Mexico markets.

www.winnipegfreepress.com/business/breakingnews/124767094.html